Zimmermann T, Thomas L, Baader-Pagler T, Haebel P, Simon E, Reindl W, et al
Zepbound Recently approved for chronic weight management , Zepbound is essentially the same medication as Mounjaro but specifically indicated for obese or overweight individuals (BMI 30 or BMI 27 with comorbidities) without diabetes
Spacing them helps both the medication and the supplement work as intended
In short, Wegovy and Ozempic are essentially identical medications under different brand names, with the primary difference lying in the dosage of semaglutide in each injection pen and the specific approvals granted for their use
Always follow the specific storage instructions on the IMP label or trial protocol
If you are needing an order shipped out on Friday, please contact us directly